An in vitro vascularized micro-tumor model of human colorectal cancer recapitulates in vivo responses to standard-of-care therapy
Open accessPublished version of a preprint
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Around 95% of anti-cancer drugs that show promise during preclinical study fail to gain FDA-approval for clinical use. This failure of the preclinical pipeline highlights the need for improved, physiologically-relevant in vitro models that can better serve as reliable drug-screening and disease modeling tools. The vascularized micro-tumor (VMT) is a novel three-dimensional model system (tumor-on-a-chip) that recapitulates the complex human tumor microenvironment, including perfused vasculature, within a transparent microfluidic device, allowing real-time study of drug responses and tumor-stromal interactions. Here we have validated this microphysiological system (MPS) platform for the study of colorectal cancer (CRC), the second leading cause of cancer-related deaths, by showing that gene expression, tumor heterogeneity, and treatment responses in the VMT more closely model CRC tumor clinicopathology than current standard drug screening modalities, including 2-dimensional monolayer culture and 3-dimensional spheroids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast to all of this, novel multicellular three-dimensional (3D) in vitro models can bridge the gap between experimental controllability and physiological relevance via reliably reproducing tissue or tumor architecture, mimicking tissue stiffness, allowing cellular crosstalk via the integration of multiple cell types and replicating various physical, morphological, structural, mechanical and”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Hachey et al., 2021
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, these physiologically relevant platforms have previously shown promise in drug discovery and testing by faithfully recapitulating pathophysiological human drug responses (Asghar et al., 2015; Benam et al., 2016; Hachey et al., 2021); hence offering the potential to advance the development of personalized therapy approaches.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Hachey et al., 2021
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To date, MPS models have been developed for the majority of human tissues and organs, and have also been established to study a diverse range of malignancies, including cancer (Baptista et al., 2022; Hachey et al. (2021; 2024); Jiang et al., 2024; Haque et al., 2022; Shen et al., 2023; Flont et al., 2023; Straehla et al., 2022).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Hachey et al., 2021
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The model has been adapted to multiple cancer types, including immunologically ‘cold’ or ‘mixed’ tumors such as breast cancer, MSS subtype colorectal cancer and ovarian cancer, which display varying degrees of vascular disruption (Jahid et al., 2022; Hachey et al., 2024), Hachey et al. (2021)).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Hachey et al., 2021
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Tumor chips have been developed to model a broad variety of cancers, including primary lung cancer, prostate cancer, breast cancer, colorectal cancer, pancreatic cancer, melanoma, liver cancer and glioblastoma (among other cancers), as well as cancer metastasis to the bone, the brain, the liver and the lung (Hachey et al. (2021; 2024); Jiang et al. (2024); Haque et al. (2022); Shen et al. (2023);”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Hachey et al., 2021
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
dbSNP: the NCBI database of genetic variation
Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502
Trapnell, C., Cacchiarelli, D., Grimsby, J., Pokharel, P., Li, S., Morse, M., Lennon, N. J., Livak, K. J., Mikkelsen, T. S., & Rinn, J. L. (2014) · Nature Biotechnology · doi:10.1038/nbt.2859 · Cited by 7,314
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
Self-citationMassagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Wnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666
Next-generation characterization of the Cancer Cell Line Encyclopedia
Ghandi, M., Huang, F. W., Jané-Valbuena, J., Kryukov, G. V., Lo, C. C., McDonald, E. R., Barretina, J., Gelfand, E. T., Bielski, C. M., Li, H., et al. (2019) · Nature · doi:10.1038/s41586-019-1186-3 · Cited by 3,394
Research works printed but not linked: 4
- RStudio Team, RStudio: Integrated Development Environment for R, RStudio, Inc., Boston, MA, 2016
- 10XGenomics, Vartrix single-cell genotyping tool
- Tickle T., Tirosh I., Georgescu C., Brown M. and Haas B., inferCNV of the Trinity CTAT Project, Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA, 2019
- Sharma G. and Stein-O'Brien G., projectR: Functions for the projection of weights from PCA, CoGAPS, NMF, correlation, and clustering, 2016
Cited by
Items 101–127 of 127
Konopka, J., Roszczyk, J., Jastrzębska, E., & Żuchowska, A. (2025) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2025.102890 · Cited by 1
Methodological innovations in perfusable vascular networks: Advancing high-density tissue models
Singh, R., Mori, N., & Kida, Y. S. (2026) · Regenerative Therapy · doi:10.1016/j.reth.2026.101109 · Cited by 4
“First, they developed a vascularized micro-tumor platform that recapitulated in vivo drug responses [68].”
Zhang, X., Zhu, X., Chen, Y., & Lu, B. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1827951 · Cited by 2
“In vitro vascularized microtumors (VMTs) serve as a comparatively typical model in colorectal cancer research (51).”
Dai, Z., Fu, G., Du, Y., Xie, Y., ZHU, J., Tao, X., Luo, Q., Chu, X., & Lei, Z. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102873 · Cited by 3
Singh, S. K., Ahuja, A., Ramankutty, R., & Ramaswamy, S. (2023) · Current Drug Therapy · doi:10.2174/0115748855266739230919110125
CDC42 Inhibitors Alter Patterns of Vessel Arborization in Skin and Tumors in vivoPreprint
Vuong, L. M., Hachey, S. J., Shiu, J., Xie, D. F., Salvador, N., Brindani, N., Bertozzi, S. M., Summa, M., Bertorelli, R., Armirotti, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.09.588609
“Tumor cells in these models maintain: 1) their in vivo gene expression profile; 2) physiologic cell-cell interactions; and, 3) responsiveness to anti-cancer drugs ( 50, 51 ).”
BackgroundLab-on-a-chip – Reform, Perform, and Transform
Parihar, A., Khare, V., & Garg, M. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837673476-00001 · Cited by 1
Design patterns of tumor-on-chips utilizing fluidic devices and their latest trends
Mori, N., & Kida, Y. S. (2024) · Drug Delivery System · doi:10.2745/dds.39.184
Amanat, M., Tandon, S., & Singh, R. (2025) · Current Diabetes Reviews · doi:10.2174/0115733998341202241202103725
Smart Bio-Inspired Structures: Organ-on-Chip
Barzegar, S., Zare, M. R., Rajabi, S., & Ahadian, S. (2025) · Springer eBooks · doi:10.1007/978-3-031-87744-5_10
Halas, P. V., Savage, H., Hachey, S. J., Lev, T., Samy, A. L. P. A., Chan, C. C. C., Jimenez, S., Domadia, R. M., Lin, I., Mallya, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.19.670946
Hachey, S. J., Hatch, C. J., Gaebler, D., Mocherla, A., Nee, K., Kessenbrock, K., & Hughes, C. C. W. (2024) · Figshare · doi:10.6084/m9.figshare.26663254
Additional file 2 of Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics
Hu, J., Liu, K., Ghosh, C., Khaket, T. P., Shih, H., & Kebebew, E. (2024) · Figshare · doi:10.6084/m9.figshare.26695116
Hachey, S. J., Hatch, C. J., Gaebler, D., Mocherla, A., Nee, K., Kessenbrock, K., & Hughes, C. C. W. (2024) · Figshare · doi:10.6084/m9.figshare.26663260
Hachey, S. J., Hatch, C. J., Gaebler, D., Mocherla, A., Nee, K., Kessenbrock, K., & Hughes, C. C. W. (2024) · Figshare · doi:10.6084/m9.figshare.26663251
Additional file 1 of Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics
Hu, J., Liu, K., Ghosh, C., Khaket, T. P., Shih, H., & Kebebew, E. (2024) · Figshare · doi:10.6084/m9.figshare.26695113
Hachey, S. J., Hatch, C. J., Gaebler, D., Mocherla, A., Nee, K., Kessenbrock, K., & Hughes, C. C. W. (2024) · Figshare · doi:10.6084/m9.figshare.26663257
A microscopically assisted limited colectomy mouse model of early colon cancer
Han, Y., Zhang, Y., Gao, D., & Zhao, X. (2026) · Animal Models and Experimental Medicine · doi:10.1002/ame2.70175
“7,26 Future research could integrate patient-derived organ - oids 26 or more sophisticated in vitro systems 27 to further enhance the predictive value and clinical translational potential of the models.”
Kao, W., Wang, L., & Tsai, F. (2026) · Biology of the Cell · doi:10.1111/boc.70072
Li, Y., Yang, Y., Zhao, L., Bian, Z., & Zhang, Z. (2026) · Bioengineering · doi:10.3390/bioengineering13080947
Organoid Coculture Models for Cancer Research and Immunotherapy
Yang, Z., Yang, H., Guangxin, L., Liu, G., Chen, Z., Tian, W., Huang, M., Liu, X., Zhao, Y., & Chen, D. (2026) · Med Research · doi:10.1002/mdr2.70087
Hydrogels and microfluidics: toward more physiologically relevant organ-on-a-chip models
Taromian, F., Mahmoudi, N., Aguilar, L. C., Stamp, M. E. M., Collins, D. J., & Nisbet, D. R. (2026) · Lab on a Chip · doi:10.1039/d6lc00628k
Tang, M., Shaoyi, L., Liang, Q., & Long, D. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1901112
Katsouleas, K., Hammel, J. H., & Gerecht, S. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1927687
“The study showed that their perfused, endothelialized constructs had lower drug sensitivity than static 2D cultures, better recapitulating in vivo therapeutic responses (Hachey et al., 2021).”
Wu, Y., Govindaraju, D. T., Lakshmikanthacharya, G. M., Hsu, T.-Y., Lin, C.-F., Sharma, S., & Anilkumar, T. S. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18101227
Zaman, M., NAZARE, T., Sarkar, A., & Mirzapourshafiyi, F. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124696
Gach, J. S., Kim, D., Vu, K., Marshall, M. E., Cachay, C., Rangwala, A. A., Kerster, G., Tifrea, D. F., Pearlman, E. M., Zahn, M., et al. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014664
Metadata
- Authors
- Hachey, S. J., Movsesyan, S., Nguyen, Q. H., Burton-Sojo, G., Tankazyan, A., Wu, J., Hoang, T., Zhao, D., Wang, S., Hatch, M. M., Celaya, E., Gomez, S., Chen, G. T., Davis, R. T., Nee, K., Pervolarakis, N., Lawson, D. A., Kessenbrock, K., Lee, A. P., Lowengrub, J., Waterman, M. L., & Hughes, C. C. W.
- Affiliations
- University of California, Irvine (US)
- Department of Molecular Biology and Biochemistry
- Corresponding author
- Hughes, Christopher C. W.
- ORCID
- Venue
- Lab on a Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2021
- Volume
- 21
- Issue
- 7
- Pages
- 1333-1351
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- PMC
- PMC8525497
- OpenAlex
- W3130617653
- Cited by
- 124
- References
- 50
- Citations by year
- 2026: 19 · 2025: 21 · 2024: 30 · 2023: 24 · 2022: 18 · 2021: 11
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Lab on a Chip (publishedVersion, cc-by-nc)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Edwards Lifesciences
- Chao Family Comprehensive Cancer Center (P30A062203)
- National Institutes of Health (CA217378, CA180122, TR-000481)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Keywords
- colorectal cancer, tumor-on-a-chip, microphysiological systems, microfluidics, tumor microenvironment, drug screening, tumor heterogeneity, tumor-stroma interactions, preclinical model validation, multicellular spheroids, gene expression
- MeSH terms
- Antineoplastic Agents, Drug Evaluation, Preclinical, Humans, Colorectal Neoplasms, Lab-On-A-Chip Devices, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.